Understanding Growth Factors in Dentistry: Emdogain, PRF GEM21 and BMP2
LOD-348-00
Dr. Richard Miron
English
Understanding Growth Factors in Dentistry: Emdogain, PRF GEM21 and BMP2
Peri-implantitis: Etiology, Risk Factors, Treatment Options, Prevention
LOD-317-00
Prof. Eric Rompen
English
Peri-implantitis: Etiology, Risk Factors, Treatment Options, Prevention
LOD-307-00
Dr. Tomas Albrektsson
English
The Story of Osseointegration - How Osseointegrated Oral Implants were Developed in Sweden by P-I Brånemark
The Biodynamics of Osseointegration Facts and Clinical Implications
LOD-207-00
Dr. Peter Schupbach
Dental implants are placed into the alveolar bone, with the expectation that they become osseointegrated and that the periimplant mucosa will heal to the abutment surface and fulfill the primary functions of the periodontal tissues, which are attachment and protection of the soft tissue and the underlying bone.<BR><BR>This requires that the rather rigid ankylotic like connection between implant and bone replaces functionally the sophisticated suspension via the periodontal ligament as offered by the evolution and, that the structural framework of the periimplant mucosa matches the architecture of the gingiva. <BR><BR>The context of an understanding of the elicited host site interfacial healing response will be reiterated for the time period immediately following implant placement up to long term behavior. The role of the implants
Ridge Augmentation Using rhPDGF Growth Factors
LOD-121-00
Prof. Massimo Simion
This lecture covers the topic of ridge augmentation using the line of growthfactors termed rhPDGF (Gem-21) mixed with xenograft, TCP and autograft for implant placement. The scientific background and the first clinical cases are discussed and demonstrated. The new bone graft material shows to be an enhancement to the current technique of GBR.
Aspectos Biologicos em Implantes Unitarios (PORTUGUESE LANGUAGE ONLY)
LOD-073-00p
Dr. Mario Groisman
Aspectos Biologicos em Implantes Unitarios (PORTUGUESE LANGUAGE ONLY)
Clinical Pharmacology - What Every Dentist Should Know
LOD-072-00
Dr. Anthony Feck
Modern dentistry has expanded the arsenal of services to restore patients oral health and cosmetic needs like never before. These changes have corresponded to an increasingly complex medical environment where patients are presenting at a more advanced age, with more medical conditions, and taking more medications. Understanding the pharmacology as it relates to their systems and how the drugs they are taking, as well as those we intend to administer affect the patient, one another, and our planned treatment is necessary for a safe and successful outcome to our planned care.
Treating the Medically Complex Patient
LOD-069-00
Dr. Adi Garfunkel
• What is the dental-medical approach to the hypertensive patient?<br> • Could we treat patients with medication induced bleeding tendency?<br> • The use of adrenalin in local anesthesia constitutes at times a contradictory subject. How do we deal with this question?<br>
Bone Morphogenetic Proteins, A Realistic Alternative to Bone Grafting<br>
LOD-054-00
Dr. Ulf Wikesjo
Surgical placement of oral implants is governed by the prosthetic design and by the morphology and quality of the alveolar bone. Often, implant placement may be difficult, if at all possible, due to alveolar ridge aberrations. In consequence, prostheticly dictated implant positioning commonly entails bone augmentation procedures. One objective of our laboratory is to evaluate the biologic and clinical potential of bone morphogenetic proteins (BMPs) including rhBMP-2, rhOP-1/rhBMP-7, rhGDF-5, other candidate biologics, bone biomaterials, and devices for alveolar ridge augmentation and implant fixation. This presentation will discuss the unique biologic potential, the clinical relevance and perspectives of BMP technologies for alveolar bone augmentation and oral implant fixation, in particular the development of a unique bone-inductive oral implant. This presentation will also address merits and explain short-comings of current treatment protocol including bone biomaterials and guided bone regeneration (GBR). BMPs have an unparalleled potential to augment alveolar bone and support implant osseointegration and long-term functional loading. Inclusion of BMPs for alveolar augmentation and osseointegration will not only enhance predictability of existing clinical protocol but radically change current treatment paradigms. Inclusion of the bone-inductive oral implant in the treatment panorama may make 'grafting' and GBR procedures altogether obsolete.
Soft Tissue Behaviour And Integration Around Dental Implants <br>
LOD-021-00
Dr. Peter Schupbach
The scientific evidence on the biomaterial surface TiUniteTM will be given and compared to other implant surfaces. Several studies confirm and support the clinical benefits of the conductive properties of TiUniteTM, allowing bone and soft tissue to adhere along the implant surface and into the pores of the surface. This results in faster osseointegration and higher biological stability, thus minimizing time at risk for effective and safe Immediate FunctionTM. The clinical implications of TiUnite as Immdiate FunctionTM, reduced marginal bone loss, soft tissue integration and predictable esthetics will be discussed. In addition the scientific evidence of micro grooves along the threads and around the implant shoulder will be given. The introduction of the Groovy technology provides yet another step in implant development. With this technology, the speed of osseointegration can be further increased. The biological stability is enhanced by up to 30% allowing the use of groovy implants in soft bone.